549 results on '"Del Re, Marzia"'
Search Results
2. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
3. Facing an un-met need in lung cancer screening: The never smokers
4. ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series
5. Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer
6. Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
7. Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
8. Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma
9. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
10. Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data
11. Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC
12. nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives
13. Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project
14. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
15. Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low‐grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis?
16. TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
17. Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
18. The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
19. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
20. Precision Medicine in Oncology: Glossary of Relevant Scientific Terms
21. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
22. Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review
23. Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial
24. Changing the way we treat KRAS G12C non-small cell lung cancers
25. Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers
26. Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment
27. The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies
28. Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer
29. Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
30. Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors
31. A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
32. Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel
33. β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation.
34. Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA
35. Understanding EGFR heterogeneity in lung cancer
36. erbB in NSCLC as a molecular target: current evidences and future directions
37. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
38. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
39. Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers
40. Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
41. DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
42. Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
43. Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
44. Multiomics approach for patient stratification and novel target identification in metastatic clear cell renal carcinoma (Meet-URO 31).
45. Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn’s Disease Treated With Anti-TNF-α Biologics
46. Empower the Potential of Trastuzumab Deruxtecan with Novel Combinations
47. Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
48. Radiomics and liquid biopsy in oncology: the holons of systems medicine
49. The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
50. Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.